Interim results from a randomized trial suggest an assay could refine treatment decisions for patients with stage Ia–IIa non-squamous NSCLC.
The post Assay Identifies Patients With Early NSCLC for Adjuvant Chemotherapy first appeared on Physician’s Weekly.
